PUBLISHER: Grand View Research | PRODUCT CODE: 1493321
PUBLISHER: Grand View Research | PRODUCT CODE: 1493321
The U.S. disposable syringes market size is expected to reach USD 3.69 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a 5.5% CAGR over the forecast period. The market is expected to grow due to increasing demand for vaccines along with growing adoption of self-administration of drugs, increasing adoption of safety syringes, and technological advancements, are supporting the market growth of U.S. disposable syringes.
The COVID-19 pandemic is anticipated to have a significant effect on the disposable syringe business in the U.S. The SARS-CoV-2 pandemic has caused a considerable increase in demand for hospital supplies, emergency supplies, medical disposables, and medications. Due to COVID-19, there has been an increase in COVID-19 vaccine production, which has led to an increase in demand for disposable syringes made in the U.S. In January 2020, in the U.S. alone, the Biomedical Advanced Research and Development Authority (BARDA) projected that 650 million to 850 million needles and syringes would be required to administer a vaccination. Therefore, the COVID-19 outbreak has immensely impacted medical disposables market and is considered to be a highly effective driver for U.S. disposable syringes market.
Moving forward, organizations like United Nations Children's Fund (UNICEF) aimed to purchase 1 billion syringes by the end of 2021 for COVID-19 vaccination operations in COVAX Facility nations. The syringes will all be of the auto-disable (AD) type, as permitted by the World Health Organization, notwithstanding the fact that the vaccines secured by the Facility may vary in their composition and storage needs. As a result, market growth is expected to accelerate in the near future.